The phrase "a complete response to study" is correct and usable in written English.
It can be used when discussing the adequacy or thoroughness of an answer or explanation related to a study or research topic.
Example: "The researcher provided a complete response to study, addressing all the questions raised by the committee."
Alternatives: "a thorough answer to the study" or "a comprehensive reply to the study".
As reported previously [ 6], 35 patients enrolled in part 1 of the study; 34 (97.1%) achieved a complete response to canakinumab at the end of part 1 (see Additional file 1: Supplementary Figure 2).
In the first step six out of 18 evaluable patients obtained a complete response: the study proceeded to the second step in which one additional complete response was achieved (complete response rate 37%95%5% confidence interval (CI =16.3 61.4)) According to the statistical design, accrual was stopped at this point (20 total patients) as we had already obtained the figures we needed.
Two CP patients exhibited complete response to chemotherapy and discontinued study treatment for resection with curative intent.
In research with long-term follow-up and repeated measurements, quick and complete response to questionnaires helps ensure a study's validity, precision and efficiency.
Two had achieved complete responses to the study treatment and had sustained remissions for 56.4 and 52 months, respectively.
The prevalence of a complete response in the present study (64%) was within the range of the previous studies.
Nonetheless, they remain the predominant source of publicly available information regarding complete response letters; to our knowledge, no sponsor chose to release a complete response letter included in this study, although nothing prevents one from doing so.
Importantly, clinical responses including a complete response were observed in this study.
26 In a preclinical study, a complete response was observed in an EGFR T790M transgenic murine mouse model of NSCLC when afatinib was used in combination with cetuximab.
In a mouse colon cancer xenograft, the addition of veliparib to irradiation extended survival from 23 to 36 days; notably, one mouse in this study experienced a complete response (CR) [26].
